Showing results (131-140 of 343) with videos related to
Sort By:
Pageof 35
British Journal of Clinical Pharmacology|March 7, 1998
Radioreceptor assay analysis of tamsulosin and terazosin pharmacokineticsK Taguchi, R F Schäfers, M C MichelPflugers Archiv : European Journal of Physiology|May 1, 1997
Renovascular and tubular effects of neuropeptide Y are discriminated by PP56 (D-myo-inositol 1,2,6-triphosphate) in anaesthetized ratsA Bischoff, M Stickan-Verfürth, M C MichelPharmacology & Toxicology|June 1, 1992
Alpha- and beta-adrenoceptors in hypertension: molecular biology and pharmacological studiesM C Michel, T Philipp, O E BroddeDeutsche Medizinische Wochenschrift (1946)|October 19, 2005
[Pharmacotherapy of stress incontinence]W H Jost, P Marsalek, M C MichelDer Urologe. Ausg. A|February 15, 2019
[Do benign prostatic hyperplasia drugs affect mood or cognition?]K F Becher, S Madersbacher, M C MichelDer Urologe. Ausg. A|June 13, 2006
[Anticholinergics for overactive bladder: does subtype selectivity play a role?]M C Michel, M M Barendrecht, M OelkeConference Proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference|February 3, 2007
Creating a text data-mining application for use in public health informaticsM C Michel, L A Bero, T BrightClinical Physiology and Biochemistry|January 1, 1990
Subtype-selective modulation of human beta 1- and beta 2-adrenoceptor function by beta-adrenoceptor agonists and antagonistsO E Brodde, A Daul, M C MichelEuropean Journal of Pharmacology|August 1, 1996
Cytoskeletal inhibitors impair Ca2+ elevations via neuropeptide Y and other Gi-coupled receptorsM C Michel, S Kaldenberg-Stasch, T WielandDer Urologe. Ausg. A|November 13, 2002
[alpha 1-receptor blockade in therapy of benign prostatic hyperplasia syndrome. Correct dosing for optimal effectiveness]R R Berges, M C Michel, U JonasPageof 35